Related Experiment Video
Updated: Apr 22, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.1K
[Asthma among mink workers]
Berit Grøntved1, Ole Carstensen, Rolf Petersen
1Arbejdsmedicinsk Klinik, Slagelse Sygehus, Ingemannsvej 18, 4200 Slagelse.
Ugeskrift for Laeger
|October 9, 2014
Summary
Two cases of asthma in mink workers suggest a higher risk. One farmer showed allergy to mink urine, while another worker experienced asthma when handling mink furs, indicating occupational asthma potential.
Area of Science:
- Occupational health
- Pulmonary medicine
- Veterinary science
Background:
- Asthma is a chronic respiratory condition affecting millions globally.
- Occupational asthma is triggered by workplace exposures, often leading to significant morbidity.
- Mink farming involves close contact with animals and their byproducts, posing potential respiratory risks.
Observation:
- A mink farmer with difficult-to-treat asthma showed a positive histamine release test to mink urine.
- A mink farm worker experienced an asthma attack specifically when handling mink furs.
- Peak flow monitoring indicated a work-related asthma pattern in the second case, despite no clear allergic markers.
Findings:
- The presented cases suggest a potential link between mink farming and the development of asthma.
- Exposure to mink urine and handling mink furs may act as occupational asthma triggers.
- Diagnostic challenges exist, as allergic sensitization is not always evident in occupational asthma.
Implications:
- These findings highlight the need for increased awareness of occupational asthma risks in the mink farming industry.
- Further research is warranted to elucidate the specific allergens and mechanisms involved.
- Implementing workplace safety measures may be crucial for preventing asthma in mink workers.
Related Concept Videos
Asthma-I: Introduction
3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma I: Introduction
40
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
40
Asthma III: Clinical Manifestations
25
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
25
Asthma-III: Symptoms and Complications
3.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Antiasthma Drugs: Muscarinic Receptor Antagonists
2.1K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
2.1K

